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Cholesterol ester accumulation: An immediate consequence Cholesterol is a critical component of plasma mem-
of acute in vivo ischemic renal injury. branes, and within renal tubular cells, it exists in an ap-
Background. Cholesterol is a major constituent of plasma proximate 1:5 ratio with plasma membrane phospholip-
membranes, and recent evidence indicates that it is up-regu- ids [1]. It interpositions itself among membrane phos-lated during the maintenance phase of acute renal failure
pholipids, affecting membrane fluidity, surface charge(ARF). However, cholesterol’s fate and that of the cholesterol
density, and polar head group interactions [2–6]. Choles-ester (CE) cycle [shuttling between free cholesterol (FC) and
terol also forms tight hydrophobic interactions withCEs] during the induction phase of ARF have not been well
defined. The present studies sought to provide initial insights plasma membrane sphingomyelin, generating so called
into these issues. “microdomains” (“rafts,” “caveolae”), which concen-
Methods. FC and CE were measured in mouse renal cortex trate a variety of signaling molecules [7–11]. Given these
after in vivo ischemia (15 and 45 minutes)/reperfusion (0 to 120
functions, it is not surprising that cholesterol exerts pro-minutes) and glycerol-induced myoglobinuria (1 to 2 hours).
tean homeostatic effects [2–11]. Presumably because ofFC/CE were also measured in (1) cultured human proximal
this, cells tightly regulate total cholesterol content, itstubule (HK-2) cells three hours after ATP depletion and in
(2) isolated mouse proximal tubule segments (PTSs) subjected subcellular distribution, and the amount that is converted
to plasma membrane damage (with cholesterol oxidase, sphin- into cholesterol esters (CEs) [12]. Total cellular choles-
gomyelinase, phospholipase A2, or cytoskeletal disruption with terol is maintained via a balance between cholesterol
cytochalasin B). The impact of cholesterol synthesis inhibition synthesis (HMG CoA reductase regulated) and low-den-
(with mevastatin) and FC traffic blockade (with progesterone)
sity lipoprotein (LDL) receptor-mediated LDL/choles-on injury-evoked FC/CE changes was also assessed.
terol uptake [12, 13]. Under normal conditions, theseResults. In vivo ischemia caused approximately threefold to
two processes are inversely related, maintaining stablefourfold CE elevations, but not FC elevations, that persisted
for at least two hours of reperfusion. Conversely, myoglobinu- cholesterol levels. Regarding intracellular distribution,
ria had no effect. Isolated CE increments were observed in approximately 90% of the total cholesterol resides in
ATP-depleted HK-2 cells. Neither mevastatin nor progester- the plasma membrane [14]. It reaches this location either
one blocked this CE accumulation. Plasma membrane injury from the endoplasmic reticulum (ER), where de novoinduced with sphingomyelinase or cholesterol oxidase, but not
synthesis occurs, or possibly from lysosomes [12], wherewith phospholipase A2 or cytochalasin B, increased tubule CE
LDL particles are degraded, releasing their cholesterolcontent. High CE levels, induced with cholesterol oxidase, par-
content. Once reaching the plasma membrane, choles-tially blocked hypoxic PTS attack.
Conclusions. In vivo ischemia/reperfusion acutely increases terol is not a static membrane constituent. Rather, it can
renal cortical CE, but not FC, content, indicating perturbed cycle back to the ER, a process that may be regulated by
CE/FC cycling. The available data suggest that this could stem “multidrug resistant” (MDR) P-glycoproteins [15–17].
from specific types of plasma membrane damage, which then Upon reaching the ER, acyl-CoA:cholesterol acyltrans-
increase FC flux via aberrant pathways to the endoplasmic
ferase (ACAT) converts cholesterol into CEs. The latterreticulum, where CE formation occurs. That CE levels are
can then be hydrolyzed back to free cholesterol (FC)known to inversely correlate with both renal and nonrenal cell
within either the cytosol or the lysosomal system. Ininjury suggests the potential relevance of these observations
to the induction phase of ischemic ARF. summary, these processes (FC transport to and from the
plasma membrane, ACAT-mediated esterification, and
CE hydrolysis) generate the “cholesterol ester” cycle
Key words: acute renal failure, cholesterol ester cycle, myoglobinuria, [12, 18, 19]. CEs are widely considered to be a cytosolic
progesterone, statins. cholesterol storage form [12]. However, that approxi-
mately 30% of total renal tubular cell CE content canReceived for publication August 9, 2000
and in revised form October 19, 2000 be hydrolyzed with membrane impermeant cholesterol
Accepted for publication November 16, 2000 esterase [20] indicates that CEs can reach and insert into
the tubule plasma membrane.Ó 2001 by the International Society of Nephrology
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Dysregulated cholesterol metabolism is a hallmark of phase of in vivo ischemia/reperfusion ARF and myohe-
moglobinuric ARF. To elucidate potential pathogenicthe maintenance phase of experimental acute renal fail-
ure (ARF) [1]. This conclusion stems from our previous changes and mechanisms further, additional experiments
were conducted in cultured human proximal tubuleobservations that by 18 to 24 hours following diverse
forms of acute renal injury (ischemia-reperfusion, glyc- (HK-2) cells. Finally, reasons for potential discrepancies
in cholesterol ester expression between in vivo versus inerol-induced myohemoglobinuria, urinary tract obstruc-
tion), approximately 20% increments in renal cortical/ vitro renal tubule injury were assessed.
proximal tubule total cholesterol content result [1, 21].
This is likely due, at least in part, to de novo cholesterol
METHODS
synthesis, given that mevastatin-induced HMG CoA re-
In vivo ischemic renal injuryductase inhibition totally prevents cholesterol accumula-
tion in postinjured cultured human proximal tubule (HK-2) Forty-five–minute ischemia-reperfusion experiments.
Male CD-1 mice weighing 25 to 35 g (Charles River Lab-cells [21]. All of the consequences of these postinjury
cholesterol increases remain unknown. However, one oratories, Wilmington, MA, USA) and maintained under
standard vivarium conditions were used for all experiments.that has been identified is that they contribute to the
“acquired cytoresistance state” (that is, decreased tubu- They were anesthetized with pentobarbital (,2 mg, ad-
ministered intraperitoneally), and then they were sub-lar susceptibility to secondary attack) [1]. This conclusion
is based on observations that cholesterol reductions in jected to a midline laparatomy, exposing both kidneys.
Body temperature was monitored with a rectal probenormal cells sensitizes them to hypoxic or toxic injury
[21], and by restoring cholesterol levels back to normal in and maintained at 368C to 378C with an adjustable heat-
ing lamp. The left kidney was subjected to ischemia bycytoresistant tubules reverses the cytoresistant state [1].
Cholesterol metabolism during the “induction phase” total vascular pedicle occlusion. The right kidney was not
subjected to ischemia, serving as a contralateral control.of ARF has remained much less well defined. In previous
work from this laboratory, we were unable to document After completing 45 minutes of renal ischemia, three
experimental groups were created: (1) no reperfusion,any changes in cholesterol levels during the induction
phase of ischemic ARF [1]. However, only total choles- in which both the left (ischemic) and right (nonischemic,
control) kidneys were removed without allowing a pe-terol content was measured, precluding any conclusion
as to cholesterol’s relative distribution between free ver- riod of vascular reperfusion (N 5 7 mice); (2) 30 minutes
of reperfusion, in which the vascular clamp was removedsus CE forms. Previous work by Molitoris et al has sug-
gested that renal ischemia may indeed cause an acute and a 30-minute reperfusion period was permitted, fol-
lowed by bilateral renal resection (N 5 6); and (3) 120reduction in apical plasma membrane cholesterol, rela-
tive to its total phospholipid content [22, 23]. However, minutes of reperfusion, in which a 120-minute reperfu-
sion period was permitted prior to bilateral renal resec-whether this change reflected absolute cholesterol reduc-
tions, a conversion to CEs, or altered intracellular choles- tion (N 5 6 mice). The kidneys were immediately iced,
and cortical tissue samples were dissected using a razorterol distribution (for example, because of cytoskeletal
disruption with altered cell polarity) was not resolved. blade. The samples were weighed, added to four parts
of cold methanol, homogenized, and extracted in chloro-In light of cholesterol’s critical role in cellular homeo-
stasis, any acute changes in cholesterol/CE expression form:methanol (1:2) as previously described in detail
[21, 25]. The samples were dried under N2 and saved forcould have significant implications for the induction
phase of ARF. Indeed, recent studies from this labora- free and esterified cholesterol analysis by gas chromatog-
raphy (GC), as described later in this article.tory have provided direct support for this hypothesis
[21]. When isolated proximal tubule (PT) segments were Impact of contralateral ischemia on renal cholesterol
levels. To assess whether the presence of unilateral is-subjected to either acute hypoxic or oxidant (Fe-medi-
ated) injury, approximately 35% decrements in tubule chemia impacts contralateral kidney cholesterol/CE lev-
els (that is, the controls used for the previously men-CE (but not FC) content resulted [21]. That comparable
CE reductions, induced in normal tubules with choles- tioned experiments), the following additional control
experiment was performed. Five mice were subjected toterol esterase, induced profound ATP depletion and ulti-
mately cell death suggested that the previously men- the previously mentioned 45-minute unilateral ischemia
experiment. At its completion, both kidneys were re-tioned observations had pathogenic relevance [21].
It is widely recognized that for a variety of reasons, moved. In addition, five kidneys were removed from
comparably anesthetized five normal mice without theirresults obtained with freshly isolated proximal tubules
may not always accurately reflect changes inherent to undergoing any renal ischemia. The cholesterol/CE lev-
els between the normal kidneys, left ischemic kidneys,the in vivo state [reviewed in 24]. Therefore, the present
study was undertaken to explore whether altered choles- and the contralateral (right) nonischemic kidneys were
compared.terol expression is in fact a correlate of the induction
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Fifteen-minute in vivo ischemia experiments. Whereas bation, in which eight flasks were maintained under con-
trol incubation conditions, with the exception of 0.1%45 minutes of in vivo ischemia causes severe tubular
necrosis and ARF [26], 15 minutes of ischemia generally ethanol/0.2% dimethyl sulfoxide (DMSO) addition (the
vehicles for the CAD addition). The cells were main-causes sublethal in vivo renal tubular damage [27]. To
ascertain whether the latter induces acute changes in tained under these conditions for three hours (corre-
sponding to a period of severe ATP depletion, but whichcholesterol expression, seven mice were treated as de-
scribed previously in this article, with the exception that is prior to the development of lethal cell injury, as de-
noted by lactate dehydrogenase (LDH) release [30] anda 15-minute, rather than a 45-minute, period of left renal
pedicle occlusion was induced. In four mice, the ischemic reconfirmed in pilot data using the current test re-
actants). After completing the three-hour incubations,kidneys and their contralateral controls were removed
after completing the 15-minute ischemic period. In the the flasks were decanted and iced, and the cells were
recovered by scraping with a rubber “policeman” in 3 mLremaining three mice, two hours of reperfusion were
permitted, followed by bilateral renal resection. The of iced Hank’s balanced salt solution (HBSS). After re-
peating this process two times, the cells were recoveredsamples were processed as noted previously in this article
and saved for cholesterol analysis. from HBSS by centrifugation, followed by lipid extrac-
tion in 1:2 chloroform methanol [21]. The lipid phase
In vivo glycerol-induced was dried under N2 and saved for cholesterol analysis, as
myohemoglobinuria experiments described later in this article. The previously mentioned
experiment was repeated in its entirety on four separateThe following experiments were undertaken to ascer-
tain whether acute changes in cholesterol expression oc- occasions, with two flasks per group per each experiment.
Impact of progesterone on HK-2 cell cholesterol profiles.cur during the induction phase of myohemoglobinuric
ARF [28]. To this end, 14 mice were briefly anesthetized Progesterone inhibits FC transport from the plasma mem-
brane (and possibly from lysosomes) to the ER, wherewith isoflurane and injected with 12 mL/kg of 50% glyc-
erol (equally divided doses into both upper hind limbs). ACAT resides [12, 31, 32]. Thus, it serves to disrupt the
normal cholesterol esterase cycle. The following experi-An equal number of anesthetized mice not subjected to
glycerol injection served as controls. At either one- or ments were undertaken to ascertain whether injury-
induced cholesterol/CE changes in HK-2 cells occur viatwo-hours postglycerol injection (6 pairs and 8 pairs of
mice at each respective time point), the mice were anes- increased cholesterol flux through these normal (proges-
terone-inhibited) pathways. To this end, T75 flasks (N 5thetized with pentobarbital. Both kidneys were removed,
and cortical tissue samples were collected. The tissues 12), prepared as described previously in this article, were
equally divided into three groups: (1) continued controlwere then subjected to lipid extraction, as noted pre-
viously in this article, and saved for cholesterol analysis. incubation conditions 3 four hours (with the addition
of 0.15% DMSO; the progesterone vehicle); (2) incuba-
Cultured proximal tubular cell experiments tion 3 four hours with 15 mg/mL progesterone (P-0130;
dissolved in DMSO; Sigma, St. Louis, MO, USA); or (3)Cholesterol/cholesterol esters following simulated isch-
emic injury. The following experiments were under- incubation with progesterone 3 one hour, followed by
the three-hour CAD challenge (in the continued pres-taken to ascertain whether ATP depletion, imposed in
cultured tubule cells, induces the same profile of choles- ence of progesterone). After a total of four hours, the
cells were harvested, and the lipids were extracted andterol changes observed in the previously described isch-
emia experiments. To this end, HK-2 cells, an immortal- saved for cholesterol/CE analysis.
Impact of HMG CoA reductase inhibition on HK-2ized human proximal tubular cell line [29], were cultured
in T75 Costar flasks (Cambridge, MA, USA) with kera- cell cholesterol profiles. The previously mentioned HK-2
cell experiment was repeated exactly as detailed with thetinocyte serum-free medium (K-SFM; GIBCO/Life Tech-
nologies, Grand Island, NY, USA) containing 1 mmol/L exception that mevastatin (10 mmol/L, in 0.1% ethanol,
M2537; Sigma Chemicals) was substituted for progester-glutamine, 5 ng/mL epidermal growth factor, 40 mg/mL
bovine pituitary extract, 25 U/mL penicillin, and 25 mg/mL one treatment. By so doing, the impact of cholesterol
synthesis on the cell injury-mediated cholesterol changesstreptomycin (378C, 5% CO2). At near confluence, the
cells were trypsinized [29], transferred to additional T75 could be assessed.
flasks, and allowed to grow for an additional 48 to 72 hours.
Isolated proximal tubule segment experimentsThe flasks of cells were divided into two groups: (1) ATP
depletion/Ca overload injury, in which eight flasks were Impact of glycine and pH on cholesterol/cholesterol ester
levels in hypoxic PT segments. (1) Hypoxic cell injury inexposed to a previously well-defined ATP depletion injury
model (the addition of 10 mmol/L Ca ionophore A23187 1 the absence of cell death. As previously noted, hypoxic
injury imposed on isolated mouse PT segments causes7.5 mmol/L antimycin A 1 20 mmol/L 2-deoxyglucose;
denoted by the term “CAD”) [30], and (2) control incu- simultaneous decrements in CEs and marked LDH re-
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lease [21]. The goal of the following experiment was to minute incubations, the percentage of LDH release was
determined, and then the tubules were processed forascertain whether the observed CE losses were merely
secondary, nonspecific consequences of hypoxic cell cholesterol/CEs.
Sphingomyelinase treatment. The previously mentioneddeath. To this end, cortical PT segments were prepared
from six mice as previously described [21] and suspended cholesterol oxidase experiment was repeated as detailed
previously in this article, substituting 0.5 U/mL of sphin-in experimentation buffer (in mmol/L: NaCl, 100; KCl,
2.1; NaHCO3, 25; KH2PO4, 2.4; MgSO4, 1.2; MgCl2, 1.2; gomyelinase (S-8633; Sigma) for cholesterol oxidase treat-
ment. The incubations were conducted for 45 rather thanCaCl2, 1.2; glucose, 5; alanine, 1; Na lactate, 4; Na buty-
rate, 10; 36 kD dextran, 0.6%; gassed with 95% O2/5% 30 minutes.
Phospholipase A2 treatment. Since ischemia/hypoxia-CO2; final pH, 7.4). After allowing a 15-minute rewarm-
ing period to 378C (isolation is performed at 48C), the mediated plasma membrane injury arises in part via phos-
pholipase A2 (PLA2) activation [reviewed in 25], the pre-tubule preparations were divided into four equal aliquots
within 10 mL Erlenmeyer flasks (1 mL of tubule prepara- viously mentioned experiment was repeated substituting
Naja Naja PLA2 (0.05 U/mL; P-7653; Sigma Chemicals)tion, 2 to 4 mg protein/mL) creating four experimental
groups: (1) control incubation 3 45 minutes (95% O2/5% [35] for the previous test reactants. The incubations were
conducted for 30 minutes.CO2); (2) incubation with O2/CO2 with the addition of
2 mmol/L glycine; (3) 30 minutes of hypoxia (95% N2/5% Cytochalasin B treatment. Because ischemic/hypoxic
plasma membrane reorientation is mediated in part byCO2; followed by 15 minutes of reoxygenation; O2/CO2);
and (4) 30 minutes of hypoxia 1 15 minutes of reoxygen- cytoskeletal disruption [22, 23], the previously mentioned
experiments were repeated substituting cytochalasin Bation in the presence of 2 mmol/L glycine. The rationale
for using glycine is that it blocks lethal cell injury/plasma (100 mmol/L, C-6762; Sigma; in order to disrupt the cy-
toskeleton) [36] for the former test agents. The incuba-membrane disruption without altering the ATP deple-
tion state [33]. At the completion of the 45-minute incu- tions were conducted for 45 minutes.
bations, lethal cell injury was assessed by the percentage
Impact of elevated cholesterol esters on the severityof LDH release, and then the tubules were subjected to
of in vitro hypoxic tubular injurylipid extraction [20] and cholesterol/CE analysis.
(2) Hypoxic injury at 7.4 versus 6.8 pH. A fundamental The following experiment was done to assess whether
an acute increase in CEs might impact the severity of hy-difference between in vivo ischemia and in vitro hypoxic
injury is the prevailing pH (falling with ischemia, but not poxic injury to isolated tubules. To this end, five sets of
proximal tubules were each divided into the followinghypoxia) [24]. The following experiment assessed whether
this difference impacts cholesterol expression during four treatments: (1) control incubation 3 30 minutes;
(2) incubation with 0.5 U/mL cholesterol oxidase 3 30ATP depletion injury. Four sets of PTS were each di-
vided into four aliquots: (1) control incubation 3 30 minutes; (3) incubation under normal oxygenated condi-
tions for 15 minutes, followed by 15 minutes of hypoxia;minutes, pH 7.4; (2) control incubation 3 30 minutes,
pH 6.8; (3) 15 minutes of hypoxia, followed by 15 minutes and (4) 15 minutes of cholesterol oxidase exposure, fol-
lowed by 15 minutes of hypoxia. After completing theof reoxygenation, pH 7.4; and (4) hypoxia/reoxygena-
tion, pH 6.8. The standard incubation buffer was used incubations, the percentage of LDH release was deter-
mined.in both limbs of the experiment (the pH being reduced
to 6.8 with HCl prior to tubule addition). After the 30-
Measurement of free cholesterol and cholesterol estersminute incubations, the percentage of LDH release was
determined, followed by tubule extraction for choles- Free and esterified cholesterol were measured by GC
using a recently described method from this laboratoryterol analysis.
[21]. In brief, the dried lipid extracts obtained from the
Effect of plasma membrane injury on cholesterol/ previously mentioned experiments were reconstituted in
cholesterol ester expression 1 to 2 mL hexane, followed by sonication and vortexing
to dissolution. To analyze FC, a 100 mL sample of eachThe following experiments assessed whether selected
forms of plasma membrane injury, induced in isolated extract was transferred to a glass culture tube containing
50 mL of an internal standard solution (stigmasterol,tubules, give rise to CE increments.
Cholesterol oxidase treatment. Five sets of isolated tu- 100 mg/mL in ethyl acetate, EtOAc). The sample was dried
under N2 and reconstituted in 100 mL of bis-(trimethyl-bules were each divided into two aliquots: (1) control
incubation 3 30 minutes and (2) incubation with 0.5 U/mL silyl)trifluoroacetamide (BSTFA, 25% vol/vol EtOAc;
Sigma). They were then transferred to an injection vial,of cholesterol oxidase 3 30 minutes (Sigma; C-7149). Of
note, cholesterol oxidase is believed to specifically attack sealed, and heated for one hour at 608C. After comple-
tion of BSTFA derivatization, a 1 mL sample was appliedplasma membrane FC residing in sphingomyelin/choles-
terol microdomains [34]. At the completion of the 30- to a Hewlett Packard 5890 Series II gas chromatograph
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fitted with a flame ionization detector and a 30 m 3 CEs in the ischemic/postischemic kidneys. This is be-
0.32 mm DB-5 (0.25 mm) column (J & W Scientific, cause there was no significant difference in CEs between
Folsom, CA, USA). The initial temperature (1008C) was completely normal kidneys and the contralateral (con-
maintained for three minutes, after which it was in- trol) kidneys taken from mice with unilateral ischemia
creased by 408C per minute to 2908C and thereafter by (5.0 6 0.2 vs. 5.1 6 0.2, respectively). The ischemic kid-
58C per minute to 3008C for five minutes. The trimethyl- neys from this experiment once again manifested striking
silyl ether of cholesterol eluted at 12.5 minutes and that CE elevations (10.8 6 2, P , 0.03 vs. either nonischemic
of the internal standard at 13.6 minutes. kidney group). FC values did not differ among these
To quantitate CEs, they were first separated from the three kidney groups (analogous to the data shown in
FC pool. This was achieved by adding samples of the Fig. 2).
hexane aliquots (700 mL, for HK-2 cells; 400 mL, for
Glycerol-induced myohemoglobinuriarenal cortex or isolated tubules) to an amino solid-phase
extraction column (3 mL, 500 mg; Varian Bond Elut, As shown in Figure 3, no significant changes in either
Harbor City, CA, USA) previously washed with hexane. CE (Fig. 3A) or FC content (Fig. 3A) were observed
The column eluant, containing esterified, but not FC, following the induction of myohemoglobinuria. This was
was saved [21]. After two subsequent column washings, true at both one and two hours after the glycerol injec-
all of the eluants were combined. The internal standard tion.
was added, and the sample was evaporated to dryness.
The esters were hydrolyzed in EtOH/30% KOH at HK-2 cell culture experiments
558C 3 45 minutes [21]. The samples were added to Impact of the ATP depletion/Ca ionophore (CAD)
2.0 mL of water, and then 3.0 mL of hexane were added. challenge. Acute cell injury, induced by CAD, caused
The hexane phase was dried under N2 and then assayed an approximate 40% increase in CE content (Fig. 4A).
for FC as described previously in this article. Previously Conversely, FC levels were not affected by CAD treat-
performed validation studies confirmed the complete ab- ment (216 6 4 and 221 6 4, CAD and control values,
sence of any contaminating FC within the CE eluant and respectively, P 5 NS; data not shown). As previously
100% efficiency in CE recovery [21]. Hence, the amount noted, a three-hour CAD challenge is insufficient in
of recovered FC resulting from CE hydrolysis was taken length to produce lethal cell injury, as defined by LDH
as the amount of CE present in the original sample. Free release.
and esterified cholesterol results were expressed as nmol/ Progesterone treatment. Progesterone (Prog) caused a
mmol phospholipid phosphate (Pi) in the original lipid significant reduction in CEs in normal HK-2 cells (Fig.
extract [21].
4B), as predicted by its ability to inhibit plasma mem-
brane FC cycling to the ER. However, progesterone didStatistics
not block the CAD-mediated CE increments, with CEsAll values are given as means 6 1 SEM. Statistical
rising by 70% (compared with progesterone treatmentcomparisons were performed by either the paired or
alone; Fig. 4B). FC was not significantly affected by pro-unpaired Student t test. If multiple comparisons were
gesterone treatment (controls, 254 6 12; progesterone,made, the Bonferroni correction was applied.
242 6 10; progesterone 1 CAD; 241 6 10, all P 5 NS;
data not shown).
RESULTS Mevastatin treatment effects. As shown in Figure 4C,
mevastatin caused a significant reduction in HK-2 cellCholesterol levels following in vivo ischemia
CE content (P , 0.001). However, mevastatin did notAs shown in Figure 1A, a threefold to fourfold increase
block CAD-mediated CE increments (rising 67% com-in CE levels was noted by the completion of 45 minutes
pared with their mevastatin controls, P , 0.005; Fig. 4C).of ischemia (I) compared with values observed in contra-
Mevastatin caused a slight but significant lowering of FClateral control kidneys. This difference persisted during
levels in noninjured cells (293 6 5 vs. 283 6 3, P , 0.05;vascular reperfusion, being observed at the completion
data not shown). However, mevastatin had no effect onof both 30- and 120-minute reflow (R). CE accumulation
FC levels in the presence of the CAD challenge (283 6was also observed after 15 minutes of ischemic challenge
3 for both the mevastatin and the mevastatin 1 CAD(Fig. 1B). However, in contrast to the 45-minute ischemic
groups).challenge, these ester elevations were fully reversed dur-
ing a two-hour reperfusion period. As shown in Figure
Isolated proximal tubular segment experiments2, in no instance did ischemia or ischemia/reperfusion
Effect of glycine on cholesterol/CE expression duringinduce a significant change in FC concentrations.
hypoxia. Glycine exerted a profound cytoprotective ef-The previously mentioned differences in CEs could
fect against hypoxic injury, reducing LDH release fromnot simply be attributed to a reduction in CEs in the con-
tralateral (nonischemic) kidneys, rather than a rise in approximately 65 to 20% (Fig. 5A). This change was
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Fig. 1. Cholesterol esters (CEs) following ei-
ther 45 minutes of ischemia (A) or 15 minutes
(B) of ischemia 1 vascular reperfusion. Both
15 and 45 minutes of ischemia (I) caused sig-
nificant increases in CE levels compared with
values found in contralateral control (cont)
kidneys. In the case of the 45-minute ischemic
insult, the CE elevations persisted for 30 and
120 minutes of reperfusion (I/R). However, in
the case of 15 minutes of ischemia, the CE
increments were dissipated during reperfusion.
Fig. 2. Free cholesterol (FC) following either
45 minutes of ischemia (A) or 15 minutes (B)
of ischemia 1 vascular reperfusion. The values
presented were derived from the same experi-
ments presented in Figure 1. No significant
changes in FC levels were observed following
ischemia (I) or ischemia/reperfusion (I/R) com-
pared with values observed in contralateral
controls.
observed in the absence of any independent glycine ef- decrements (Fig. 5B). Neither hypoxia nor glycine had
any significant effect on FC levels (controls, 232 6 19;fect on LDH release (as reflected by the oxygenated
“control” tubule results; Fig. 5B). As previously demon- glycine, 245 6 92; hypoxia, 246 6 22; hypoxia 1 glycine,
244 6 27; data not depicted).strated [20], hypoxia caused an approximate 30% de-
crease in CE in isolated tubules (P , 0.015 vs. controls; Impact of pH on tubule cholesterol expression during
hypoxia. Incubating isolated tubules under oxygenatedFig. 5B). Despite the fact that glycine almost completely
blocked lethal tubule injury, as assessed by LDH release, conditions at pH 6.8 versus 7.4 had no impact on LDH
release (Fig. 6A). However, the extent of hypoxia-inducedit had no impact whatsoever on hypoxia-induced CE
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Fig. 3. Cholesterol ester (A) and free choles-
terol (B) levels in renal cortex either one or
two hours after glycerol-induced myohemo-
globinuria. In no case were altered levels ob-
served, in contrast to values observed in con-
trol mouse kidneys.
Fig. 4. Cholesterol ester levels in control hu-
man proximal tubule (HK-2) cells, in HK-2
cells challenged with ATP depletion/Ca over-
load injury (CAD), and CAD injury con-
ducted in the presence of either progesterone
or mevastatin. (A) The CAD injury protocol
(33 hours) caused a significant (,40%) in-
crease in CE levels. (B) Despite the fact that
progesterone (Prog) significantly decreased
CEs under otherwise normal (control) condi-
tions, it did not attenuate CAD-mediated CE
elevations (rising 70% over their progesterone
controls). (C) Mevastatin (Meva) significantly
lowered CEs under normal (Control) culture
conditions. However, it did not block CAD-
mediated CE accumulation (rising 67% over
their Meva controls).
LDH release was reduced by approximately 35% when cholesterol/ester expression. Cholesterol oxidase treat-
ment caused a striking (15- to 20-fold) increase in CEconducted at pH 6.8 versus 7.4 (P , 0.001). This is consis-
tent with previously reported findings [37–39]. levels, with essentially reciprocal reductions in FC con-
tent being apparent (Table 1). This was despite any in-Hypoxia at pH 7.4 caused the usual 30% decrease in
CEs (Fig. 6B). However, when hypoxia was induced at pH crease in lethal cell injury, as assessed by LDH release
(Table 1). Attacking cholesterol/sphingomyelin micro-6.8, there was a complete block in CE reductions (Fig. 6B).
Buffer pH had no apparent effect on FC levels under domains with sphingomyelinase also caused significant
but far more modest CE increments (,50%). Althoughoxygenated conditions (203 6 3 and 200 6 6, pH 7.4
and 6.8, respectively). However, under hypoxic condi- a reciprocal reduction in FC was also observed, it did
not achieve statistical significance. Plasma membranetions, pH 6.8 resulted in slightly increased FC levels
(224 6 7 vs. 203 6 5, respectively, at pH 6.8 and 7.4, alterations induced with either PLA2 or with the cy-
toskeletal disrupting agent cytochalasin B tended torespectively, P , 0.01; data not depicted).
Effect of plasma membrane/cytoskeletal injury on tubule slightly decrease, rather than increase, CE levels (sug-
Zager et al: CEs and ischemic injury 1757
Fig. 5. Effect of glycine on lactate dehydrogenase (LDH) release and cholesterol ester (CE) changes during hypoxic injury to isolated tubules.
(A) Administration of 2 mmol/L glycine ( ) almost completely blocked hypoxia-mediated LDH release without exerting an independent effect
under oxygenated (control; h) conditions. Despite this protective effect, glycine did not attenuate hypoxia-mediated CE reductions (B).
gesting suppression rather than stimulation of FC move- tated in the immediate aftermath of ischemic injury [1],
ment from the plasma membrane to the ER; Table 1). no change in cholesterol content was observed. Thus, it
Impact of cholesterol oxidase on tubule hypoxic injury. was concluded that renal tubular cholesterol accumula-
Cholesterol oxidase had no significant effect on LDH tion is a hallmark of the maintenance phase, but not the
release under oxygenated conditions, reproducing the induction phase, of ARF. It is noteworthy that in that
results given in Table 1. However, pretreatment of tu- previous study [1], cholesterol was measured with an
bules with this enzyme for 15 minutes decreased tubule assay that quantifies only total cholesterol content. Given
vulnerability to superimposed hypoxic attack (decreas- that #1% of tubular cholesterol is in its ester form [21],
ing percentage LDH release from 61 6 4% to 37 6 4%, the employed assay did provide a useful gauge of total
P , 0.04). Of note, the dose of cholesterol oxidase used cellular cholesterol content. However, by its nature, it
in this experiment, 0.5 U/mL, contrasts with the choles- cannot assess CEs and, hence, the integrity of the “CE
terol oxidase dose that our laboratory had previously cycle.” In a more recent study using GC [21], we observed
found to induce lethal cell injury to isolated tubule cells that CEs may, in fact, be highly relevant to the induction
(2 to 4 U/mL) [20]. phase of ischemic ARF. This conclusion was based on the
finding that acute hypoxic injury imposed on isolated
DISCUSSION proximal tubules caused an abrupt 30% decline in CE
content. When this same degree of CE reduction wasA previous report from our laboratory documented
reproduced in isolated tubules with exogenous choles-that by 18 to 24 hours following diverse forms of renal
terol esterase, lethal cell injury resulted [21]. Thus, theseinjury, total renal cortical/tubular cell cholesterol levels
findings led to the conclusion that CE reductions couldrise by approximately 20% and that this change mecha-
be a concomitant and potential mediator of hypoxic in-nistically contributes to the “acquired cytoresistance”
state [1]. However, when cholesterol levels were quanti- jury, at least in freshly isolated proximal tubules [21].
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Fig. 6. Effect of pH on LDH release and CE
changes during hypoxic injury to isolated tu-
bules. Incubating tubules at pH 6.8 (vs. 7.4)
attenuated hypoxic injury (LDH release; )
without exerting an independent effect under
oxygenated (control, h) conditions (A). Where-
as hypoxia caused CE reductions at pH 7.4,
it failed to do so at pH 6.8 (indicating that pH
is a determinant of CE expression in isolated
tubules).
Table 1. Cholesterol ester and free cholesterol levels in isolated latter finding stems from more severe initial ischemic
tubules subjected to diverse forms of plasma membrane or
damage (as dictated by a longer duration of ischemia) orcytoskeletal damage
from more severe reperfusion injury remains unknown.
Cholesterol Free It is noteworthy that 12 mL/kg glycerol injection, whichGroup esters cholesterol LDH release
induces profound myohemoglobinuric renal injury, but
Cholesterol oxidase 4463b 291611a 1461% only modest ATP depletion [40], had no impact whatso-Control 2.560.1 327612 1261%
ever on CE content during the induction injury phaseSphingomyelinase 3.360.4a 298617 1762%a
Control 2.160.1 320613 1361% (0- to 2-h post-glycerol injection). This suggests that CE
accumulation during ischemia is relatively specific to thisPLA2 1.560.2 251620 2461%a
Control 2.060.3 253620 1862% form of injury, rather than simply reflecting acute cell
injury per se.Cytochalasin B 2.260.1a 355625 1962%
Control 2.960.1 350618 1862% That CEs rose without a concomitant increase in FC
indicates a disturbance of the CE cycle. To our knowl-All values are given as nmol/mmol inorganic phosphate in isolated tubule
extracts (mean 6 1 SEM). For experimental details, see text. edge, this is the first documentation that this phenome-a P,0.05, b P,0.01
non is an acute consequence of in vivo ischemic renal
damage. The CE increments seem somewhat paradoxical
in two regards: First, cholesterol’s fate is opposite to that
Given the potential caveats inherent to studies em- of phospholipids during ischemia. Whereas PLA2-medi-
ploying isolated PTSs (for example, isolation artifacts ated phospholipid de-esterification occurs, in the case of
[24]), the goal of the present investigation was to define cholesterol, esterification results. Second, during hypoxic
better the fate of CEs during in vivo ischemic/reperfu- injury imposed on isolated proximal tubules, CEs acutely
sion injury. To this end, two lengths of ischemia (15 and fall, not rise, as noted previously in this article. Whereas
45 min) were employed to induce sublethal and lethal multiple potential explanations can be offered for the
tubular damage, respectively [26, 27]. As shown in Figure differing fate of CEs versus phospholipids during in vivo
1, each of these ischemic protocols induced dramatic CE ischemia (for example, nothing would necessarily dictate
increments by the end of the ischemic period. Interest- parallel changes in these highly different membrane con-
ingly, a comparable degree of CE elevation was noted stituents), the reason(s) for CE decrements versus incre-
at the end of the 15- and 45-minute ischemic challenges, ments during in vitro hypoxic versus in vivo ischemic
suggesting that it is the presence of severe ATP depletion tubular damage remains far more obscure. Hence, addi-
and not necessarily its length that determines initial CE tional experiments were performed in an attempt to par-
accumulation. With the 15-minute ischemic insult, the tially elucidate this issue.
CE elevations were dissipated during early reperfusion, The first possibility considered is that hypoxic injury
consistent with the fact that this is a readily reversible is so rapidly expressed in isolated tubules (for example,
form of tubular damage [27]. Conversely, with the 45- ,60% cell death within 15 minutes) that insufficient time
minute ischemic challenge, the CE elevations persisted un- exists for CE accumulation to result. Stated differently,
the observed CE reductions during hypoxic tubular in-abated for up to two hours of reperfusion. Whether the
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jury could simply be an epiphenomenon, reflective of At least three perturbations could explain increased
CE accumulation in response to cell injury: (1) increasednecrotic cell death. In contrast, in vivo ischemic tubule
necrosis generally requires hours, not minutes, to be- cholesterol synthesis, followed by rapid esterification,
(2) decreased CE hydrolysis, or (3) plasma membranecome fully expressed [26, 27]. To explore this potential
explanation for differing in vitro versus in vivo results, injury, triggering increased FC trafficking to the ER,
where rapid esterification occurs. The first possibility hasisolated tubules were subjected to hypoxic injury with
and without 2 mmol/L glycine, a potent cytoprotectant been excluded, given that mevastatin completely failed
to block HK-2 cell injury-mediated CE increments. That[33]. Glycine almost completely prevented lethal hypoxic
injury, as assessed by LDH release. In spite of this, CE mevastatin decreased free and esterified cholesterol in
coincubated control cells indicates that the drug did exertreductions remained fully expressed. This makes it clear
that CE loss during in vitro hypoxic injury is not simply its expected biologic effect. The second possibility, de-
creased CE hydrolysis, cannot be excluded at this time.a secondary consequence of necrotic cell death.
In vitro hypoxia is generally induced at a physiologic Nevertheless, it appears an unlikely explanation for CE
accumulation, given the rapidity and degree of the CEpH (that is, a buffer pH of 7.4). However, during ische-
mia, tissue acidosis (pH ,6.8) rapidly develops. It has increments (for example, threefold to fourfold within 15
min of in vivo ischemia). Furthermore, cholesterol es-been noted by multiple laboratories that pH has a pro-
found effect on cellular responses to hypoxic injury, cul- terase activity should rise, not fall, during ischemia, given
its pH optimum of 6.5 [41]. In light of these considera-minating into a modest cytoprotective effect [38, 39].
Given these considerations, we tested the hypothesis that tions, increased CE formation derived from pre-existent
plasma membrane cholesterol pools, rather than de novodifferences in pH during in vitro versus in vivo oxygen
deprivation injury might explain disparate CE expres- cholesterol synthesis or decreased CE hydrolysis, seems
most likely.sion. To this end, isolated tubules were exposed to hyp-
oxia at either 7.4 or 6.8 pH. The acidotic milieu com- It is well recognized that substrate (FC) availability is
the prime determinant of CE formation [12]. Thus, ifpletely prevented the hypoxia-mediated CE losses and
slightly, but significantly, raised tubule FC content. cell injury were to increase FC delivery from the plasma
membrane to the ER, increased ACAT-mediated CE for-Based on these results, the following conclusions can be
drawn: (1) pH is clearly an important determinant of mation should result. Given that cholesterol is concen-
trated within plasma membrane cholesterol-sphingomy-cholesterol/CE expression during hypoxia, and (2) pH
appears to be only a partial explanation for the differ- elin microdomains, we tested whether specific damage
to these regions with either cholesterol oxidase or sphin-ences in cholesterol expression observed during in vivo
versus in vitro injury, given that acidosis, while pre- gomyelinase would acutely increase tubule cell CE con-
tent (implying increased plasma membrane-ER traffick-venting CE loss, did not allow CE increments to develop.
The next possibility that was considered is whether ing). Indeed, this appeared to be the case since both
agents, particularly cholesterol oxidase, increased CEtubule isolation injury might, in some way, prevent ester
accumulation during an ATP depletion state. To pursue levels. It is noteworthy that both cytochalasin B (used to
simulate ischemia-induced cytoskeletal disruption withthis issue, CE levels during acute cell injury were assessed
in cultured proximal tubule epithelial (HK-2) cells. De- secondary plasma membrane changes) and PLA2 each
tended to decrease, not increase, tubule CE content. Thesespite their obvious differences with the in vivo state, they
do permit experiments to be conducted in the absence results imply that damage to cholesterol-rich domains
(caveolae, rafts), rather than plasma membrane damageof membrane isolation artifacts. When the HK-2 cells
were subjected to the acute ATP depletion challenge, the per se is most effective in triggering plasma membrane
cholesterol/ER trafficking. Interestingly, progesteronesame qualitative cholesterol profiles to those observed
during in vivo ischemia resulted, namely, CE increments did not block cell injury-mediated CE increments, either
in HK-2 cells or during in vivo ischemia experimentswithout a change in FC content. It is notable that the
magnitude of the CE elevations was less impressive than (data not presented). This implies that the hypothesized
increase in plasma membrane-ER cholesterol traffickingthose resulting from in vivo ischemia. A large number
of theoretical explanations for this quantitative differ- occurs via an aberrant (nonprogesterone inhibitable)
pathway. Indeed, this result does not seem surprising,ence can be surmised (for example, in vivo tubules have
a much more extensive brush border/plasma membrane given that extensive plasma membrane reorganization,
including brush border internalization [42], is known tosurface, possibly allowing for more cholesterol cycling;
the pH issue noted previously in this article). Neverthe- result from ischemic renal damage.
Finally, it is interesting to speculate about whether CEless, having identified an in vitro model system that quali-
tatively recapitulated the cholesterol changes found dur- accumulation during in vivo ischemia could potentially
modulate the acute evolution of tubular damage. Severaling in vivo ischemia, it was employed in an attempt to
gain mechanistic insights into the pathways involved. pieces of evidence provide indirect support for such a pos-
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sibility: First, it has already been established that when APPENDIX
CE levels are experimentally depressed in tubular cells Abbreviations used in this article include: ACAT, acyl-CoA:choles-
terol acyltransferase; ARF, acute renal failure; ATP, adenosine 59-tri-(with cholesterol esterase), extensive cell injury results
phosphate; BSTFA, bis-(trimethylsilyl)trifluoroacetamide; CAD, Ca 1[20]. Second, approximately 63 CE elevations correlate
A23187 1 antimycin A 1 deoxyglucose; CE, cholesterol ester; ER,
with the emergence of the acquired cytoresistant state endoplasmic reticulum; FC, free cholesterol; GC, gas chromatography;
[21]. Third, several studies performed in non-renal cells HBSS, Hank’s balanced salt solution; HK-2, human proximal tubule;
HMG-CoA, 3-hydroxy-3-methlglutaryl coenzyme A; I, ischemia;have suggested that CE formation can have a cytoprotec-
K-SFM, keratinocyte serum-free medium; LDH, lactate dehydroge-tive effect [12, 43, 44], and fourth, in the present study, nase; LDL, low density lipoprotein; MDR, multi-drug resistant; PLA2,
when CEs were acutely raised in isolated tubules with phospholipase 2; Prog, progesterone; PT, proximal tubule; R, reflow.
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